Stay updated on Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a small site update. No study content or functionality changes are indicated.
    Difference
    0.0%
    Check dated 2026-07-21T12:49:31.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Results Submitted has been added, replacing No Results Posted, indicating that study results are now submitted. The page revision was updated from v3.6.0 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-06-30T02:03:32.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    New recruitment status text 'No longer looking for participants' appears on the page, clarifying enrollment status. The page also adds multiple help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, while the older 'Intervention / Treatment' label and 'Revision: v3.5.5' note were removed in favor of a new 'Revision: v3.6.0' note.
    Difference
    0.3%
    Check dated 2026-06-15T20:46:27.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a new build deployment. This appears to be a behind-the-scenes update rather than a modification of the trial information.
    Difference
    0.0%
    Check dated 2026-06-08T17:09:19.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, indicating deployment of a new build. This is a behind-the-scenes update and does not alter visible content.
    Difference
    0.0%
    Check dated 2026-05-18T13:15:56.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than any modification to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T07:34:50.000Z thumbnail image

Stay in the know with updates to Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.